Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Research Support, Non-U.S. Gov't

Comparative Study

Clinical Trial

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Clinical Trial, Phase III

Multicenter Study

Publication Year

From

Quick links

Individual year

2021

2010

2009

2008

2007

2006

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Purinergic P2 Receptor Antagonists""[mesh_terms]

12 Results

Searching titles within these results

Benefit of ADP receptor antagonists in atherothrombotic patients: new evidence.

J Bogousslavsky

Cerebrovascular diseases (Basel, Switzerland) 2001;11 Suppl 2():5-10

Full Text

Abstract

Plant natural products as source of new P2 receptors ligands.

Betina Quintanilha Magalhães, Paulo Anastácio Furtado Pacheco, Roberta Tosta Diogo, Robson Xavier Faria

Fitoterapia 2021;146():104709

Full Text

Abstract

Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.

John H Alexander, Robert W Emery, Michel Carrier, Stephen J Ellis, Rajendra H Mehta, Vic Hasselblad, Philippe Menasche, Ahmad Khalil, Robert Cote, Elliott Bennett-Guerrero, Michael J Mack, Gerhard Schuler, Robert A Harrington, Jean-Claude Tardif

JAMA 2008;299(15):1777-87

Full Text

Abstract

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

Peter P Toth

Postgraduate medicine 2009;121(1):59-72

Full Text

Abstract

A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study.

Ascan Warnholtz, Mir Abolfazl Ostad, Nathalie Velich, Christine Trautmann, Reinhard Schinzel, Ulrich Walter, Thomas Munzel

Atherosclerosis 2008;196(2):689-95

Full Text

Abstract

Haemorrhagic stroke during anti-platelet therapy.

M Cattaneo

European journal of anaesthesiology. Supplement 2008;42():12-5

Full Text

Abstract

Protective effect of pyridoxal-5-phosphate (MC-1) on perioperative myocardial infarction is independent of aortic cross clamp time: results from the MEND-CABG trial.

J C Tardif, M C Guertin, R Harrington, D E Kandzari, R Emery, M Carrier

The Journal of cardiovascular surgery 2008;49(2):249-53

Full Text

Abstract

P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production.

D Ferrari, M Idzko, S Dichmann, D Purlis, C Virchow, J Norgauer, P Chiozzi, F Di Virgilio, W Luttmann

FEBS letters 2001;486(3):217-24

Free Full Text

Abstract

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.

Anthony Defranco, Alex Malinin, Alex Pokov, Malcolm Spergling, Kenneth Schwartz, Dianne Schwartz, Ehtisham Mahmud, Dan Atar, Victor Serebruany

Thrombosis research 2007;119(3):277-84

Full Text

Abstract

Treatment of airway mucus hypersecretion.

Peter J Barnes, Duncan F Rogers

Annals of medicine 2006;38(2):116-25

Full Text

Abstract

Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.

Robert W Colman, Wei Zhang

Blood 2007;110(5):1475-82

Free Full Text

Abstract

Implementing genotype-guided antithrombotic therapy.

Richard L Seip, Jorge Duconge, Gualberto Ruaño

Future cardiology 2010;6(3):409-24

Free Full Text

Abstract

Results: 1 – 12 / 12

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Purinergic P2 Receptor Antagonists""[mesh_terms]

Benefit of ADP receptor antagonists in atherothrombotic patients: new evidence.

Plant natural products as source of new P2 receptors ligands.

Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study.

Haemorrhagic stroke during anti-platelet therapy.

Protective effect of pyridoxal-5-phosphate (MC-1) on perioperative myocardial infarction is independent of aortic cross clamp time: results from the MEND-CABG trial.

P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production.

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.

Treatment of airway mucus hypersecretion.

Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.

Implementing genotype-guided antithrombotic therapy.

Results for
""Purinergic P2 Receptor Antagonists""[mesh_terms]